Credent Connect N Care IPO Opens Today: Price Band, GMP and What Investors Should Know

Credent Connect N Care, a New Delhi-based healthcare logistics and services provider, opened its initial public offering for subscription on Thursday, aiming to raise Rs 94 crore through a fresh issue of shares on the NSE Emerge SME platform.

The IPO is priced in a band of Rs 179 to Rs 189 per share, with a lot size of 600 shares. The issue, comprising entirely a fresh issuance of 49.68 lakh equity shares, will remain open for subscription through August 17, with listing tentatively scheduled for August 20. Hem Securities is acting as the sole book-running lead manager, while Kfin Technologies is the registrar to the issue.

Ahead of the public offer, the company raised Rs 26.53 crore from anchor investors by allotting shares at the upper end of the price band. Anchor investors included Sunil Singhania's Abakkus Venture Opportunities Fund, Motilal Oswal Finvest, Hem Growth Opportunities Fund, Mint Focussed Growth Fund and 360 ONE LVF Treasury Solutions Fund, among others, lending some institutional credibility to the offering ahead of retail bidding.

Incorporated in 2015, Credent Connect N Care operates a business-to-business model providing technology-enabled logistics, workforce and supply chain solutions to diagnostic laboratories, in-vitro diagnostics companies, pharmaceutical firms, hospitals and clinics across India. The company says it works with more than 2,500 laboratories and maintains a field force of over 6,500 professionals supporting last-mile healthcare logistics nationwide, built up over more than 14 years of operations.

Financially, the company reported net profit of Rs 18.45 crore on revenue of Rs 214.43 crore for the year ended March 2026, with EBITDA of Rs 28.46 crore. Revenue from operations surged nearly 175% year-on-year, while EBITDA rose sharply from Rs 4.99 crore a year earlier and profit after tax climbed from a much smaller base, reflecting a period of rapid expansion. At the IPO price, the company would command a market capitalisation of roughly Rs 345 crore.

The grey market premium for the issue was last quoted around Rs 50 per share, implying a potential listing gain of about 26% over the upper end of the price band, though unlisted market premiums are known to fluctuate significantly in the days before an IPO closes and should not be treated as a reliable predictor of listing performance.

Retail investors are required to apply for a minimum of two lots, or 1,200 shares, amounting to roughly Rs 2.27 lakh at the upper price band, positioning this squarely as a high-ticket SME offering aimed at more affluent retail and high-net-worth investors rather than small first-time applicants.

Analysts have flagged some caution alongside the growth story. Equivision, which has assigned the issue a "neutral" rating, noted that much of the company's recent growth has come from subsidiary expansion and consolidation rather than purely organic operations, raising questions about the sustainability of the pace of growth. The business also remains working-capital intensive with elevated receivables and negative operating cash flow, while customer concentration is notable, with the top 10 customers accounting for nearly 82% of FY26 revenue.

This article is an original editorial summary based on publicly reported information. It has been independently written for publication and does not reproduce content from any single source.